The field of ion mobility mass spectrometry (IM-MS) has developed rapidly in recent decades, with new fundamental advances underpinning innovative applications.
| INTRODUCTION
There is no doubt that mass spectrometry (MS) has had an enormous impact in biological research. In particular, the emergence of proteomics has led to major technological advances and workflow designs that allow for identification and quantification of ever larger sets of proteins, which in turn has revolutionized our understanding of the proteome and its diverse roles in biological function. Such advances have not only benefitted high-throughput proteomics, but have also expanded MS into the arena of molecular and structural biology. Today, MS methods are increasingly utilized to describe the three-dimensional structures and binding interactions of large biomolecules, with the aim to improve our understanding of biomolecular assemblies and their function.
In parallel with progress in biological MS, developments in ion mobility (IM) in recent years have seen increasing applications of this technology in biological fields. Strong synergies between MS and IM exist due to their ability to describe complementary information for gas-phase ions. MS separates ions based on their mass-to-charge (m/z) ratio, which gives details of the identity and molecular composition of an analyte. In contrast, IM separates ions based on their differential mobility through a buffer gas, and therefore provides an additional dimension of separation that may enable resolution of otherwise indistinguishable ions (such as isobaric structural isomers) or can determine structural and dynamic information by measurement of the rotationally averaged collision cross section (CCS). Although the coupling of IM and MS was first demonstrated as early as 1961, 1 routine use of hybrid IM-MS instrumentation has largely only become possible in recent decades due to improved methods for confining, focusing and transmitting ions across the variable pressure regimes of the two separation technologies.
IM-MS is generally utilized in one of three ways; as an added dimension of separation for increasing peak capacity, as an extra metric for analyte identification, and as a geometric constraint for generation of structural models. The latter application explicitly relies on converting the IM measurement (commonly drift time) to a quantitative measurement of CCS in order to represent the fundamental size and shape preferences of analytes in the gas phase. While it is clear that the coupling of IM with MS can significantly enhance analytical experiments as defined by a range of measures, including speed, sensitivity, selectivity and dynamic range, this perspective focuses on the advances in IM-MS technology enabling quantitative CCS measurement of proteins and protein complexes, and recent efforts to interpret this data for the generation of structural models. In particular, it highlights a number of important considerations to ensure that the CCS value is meaningful and informative in biomacromolecular structure determination to reinforce the role and potential of IM-MS in structural biology.
| BASIC PRINCIPLES OF CCS MEASUREMENT
In general terms, IM separates ions based on the rate at which they migrate through a buffer gas under the influence of an external electric field. Importantly, the mobility of an ion is related to structural features such as charge and CCS, the latter of which can be used to infer information about three-dimensional conformations. Modern IM-MS instrumentation utilizes this basic separation principle in a variety of ways, and in combination with a range of MS platforms. For biomacromolecules, the IM separation technologies available for quantitative size determination are essentially of four types; drift tube, travelling wave, trapped ion and differential mobility analyzers. Aspects of these IM-MS techniques and their applications have been described in detail in several recent notable reviews. [2] [3] [4] [5] [6] [7] Consequently, only a brief summary of these IM separation approaches is provided here.
| Drift tube ion mobility
Time-dispersion forms the basis of separation in the oldest and conceptually simplest form of IM spectrometry, namely drift tube ion mobility spectrometry (DTIMS). Here, ion packets are gated into a drift tube (with lengths of single linear drift tubes typically ranging from a few centimeters up to two meters), where they are propelled by a static uniform low electric field. Usually a neutral, inert gas such as helium, argon or nitrogen at pressures of 1-15 mbar is used to fill the drift tube, which restricts ion motion. The velocity of ions is related to their mobility in the buffer gas, which, in the 'low field limit' where the ratio between electric field strength and gas density is small (≤2 × 10 −17 V cm 2 ), 8 is proportional to the ion CCS (Ω) according to the Mason-Schamp equation: 9
where K 0 is the reduced mobility (measured at standard temperature and pressure), z is the charge state of the ion, e is the elementary charge, N is the number density of the drift gas, μ is the reduced mass of the ion-neutral drift gas pair, k B is the Boltzmann constant and T is the gas temperature.
The CCS parameter represents the rotationally averaged surface area of the ion which is available for interaction with the buffer gas;
a smaller CCS results in fewer collisions with the buffer gas which otherwise impede ion motion, and therefore a shorter drift time through the drift tube. Consequently, measuring the drift time or arrival time distribution of a population of ions provides gas-phase structural information ( Figure 1A ). Although DTIMS offers comparatively high IM resolving power (often defined in terms of the centroid arrival time FIGURE 1 Characteristics of different ion mobility separation methods for the measurement of collision cross section. A, Drift tube ion mobility: Packets of ions travel along a potential gradient opposing a constant gas flow. Ions with larger CCS experience more collisions with the gas, and hence traverse the cell with reduced velocity (greater drift time). B, Travelling wave ion mobility: Alternating phases of RF voltage are applied to a stacked ring ion guide (top), to which a sequence of symmetric potential waves is superimposed (bottom). The ions propagate through a reverse flow of buffer gas along the potential wave front; ions with low mobilities experience the most wave roll over events as a result of increased collisions with the gas, and exit the cell last. C, Trapped ion mobility: Ions are trapped in the TIMS tunnel at the point where the force of a gas flow matches the opposing force of an electrical field in the tunnel (top). Ions are portrayed aligned along the electrical field gradient (bottom), and are selectively released in order of increasing mobility as the electrical field is ramped down. D, Differential mobility analyzer: In this geometry, ions are introduced through a slit on the upper plate, and dispersed into a fan with trajectories defined by combined action of orthogonal gas flow and applied electric field. Ions of a selected mobility are drawn through an exit aperture to the mass spectrometer of the IM peak, normalized to peak width, i.e. t/Δt) it suffers from poor ion transmission efficiency, which, until more recent developments, limited applications in structural biology. Newer generation DTIMS-MS instruments have encompassed noteworthy innovations to the basic drift tube design, including the use of electrostatic and electrodynamic fields to accumulate ions before the drift cell 10 and focus radially diffuse ions. [11] [12] [13] Tandem DTIMS has also been used to interrogate mobility-selected ions in a manner analogous to MS/MS experiments, and assess gas-phase stability and microconformational states. 14, 15 2.2 | Travelling wave ion mobility the buffer gas present in the TWIMS sector gives rise to a drag force, meaning those ions with greater CCS (low mobility) slip behind the wave front more frequently (also known as 'roll over') and therefore take longer to traverse the mobility cell ( Figure 1B ).
As the applied electric field is not constant in TWIMS, the direct relationship between CCS and mobility is no longer applicable, and hence CCS cannot be measured empirically. Attempts have been made to describe the fundamentals of TWIMS using a priori theory and numerical simulations of ion dynamics; 17, 18 however, these approaches are not yet applicable to macromolecular ions.
Consequently, drift time is correlated to CCS through an exponential relationship, derived by calibration of the IM cell using reference ions of known CCSs under defined conditions (gas type/pressure, travelling wave speed/height, etc.). 19 Nevertheless, the early commercialization of the TWIMS technology, and its suitability for observing high m/z ions mean that the majority of IM-MS datasets for biomacromolecules generated to date have used these TWIMS instruments.
| Trapped ion mobility
Trapped ion mobility spectrometry (TIMS) coupled with MS is a relatively recent addition to the field. Rather than moving ions through a stationary gas, as in DTIMS, ion separation in TIMS is achieved by holding ions stationary in a moving column of gas, and selectively ejecting these ions based on differences in mobility. A TIMS device is a modified ion funnel, through which ions are propelled by a gas flow in the presence of an axially variable, opposing electric field ( Figure 1C ). An ion with a mobility of K is trapped at the point where the electric field strength is such that the ion drift velocity equals the carrier gas flow velocity. Following the trapping event, ions are sequentially eluted with ascending mobilities by gradually reducing the electric field strength. A key advantage of this approach is that the physical dimensions of the IM cell can be significantly reduced (approximately 5 cm) while achieving high resolving power (R ∼ 300), duty cycle (100%), and efficiency (∼80%). 6 Importantly, the fundamental physics of TIMS is the same as that in DTIMS and the relationship between mobility and CCS still applies; hence, it is possible to measure ion CCS using first principles for structural characterization.
| Differential mobility analyzers
Differential mobility analyzers (DMAs) operate by introducing ions into a stream of buffer gas flowing with a fixed velocity in the region of an external magnetic field, causing the ions to follow trajectories dependent on their mobility. In a simple geometry, a uniform electric field is applied between two parallel plates, with the ion velocity normal to the electric field. Ions are introduced via an inlet slit and exit through an offset aperture at a fixed distance downstream. The voltage between the two plates is scanned to sequentially sample ions of selected mobility ( Figure 1D ). Consequently, rather than measuring ion drift time, DMAs measure the voltage required to transmit the ions, which is inversely proportional to mobility. Conversion of the DMA voltage measurement to CCS requires a rigorous calibration methodology. [20] [21] [22] Nevertheless, DMAs have been utilized for size measurement of a range of protein assemblies, 22-24 although many of these have been in the absence of coupled MS measurements.
The performance of DMAs with nanometer-size objects is severely limited by Brownian motion; however, resolving powers in excess of 50 have recently been described using high-transmission parallel-plate DMAs, 25 which can be coupled as a front-end device to almost any mass spectrometer with an atmospheric pressure ion source.
Consequently, unlike most other IM separations, the DMA can be used to measure the mobility of electrosprayed ions without the need for energetic confinement or declustering, or even vacuum interfaces. This instrument has since undergone multiple design revisions to alter both the traveling potential waveform and the drift region pressure, thereby increasing IM resolution (Synapt G2), and the source and ion transfer optics to improve ion transmission (Synapt G2-S and G2-Si).
| IM-MS for the masses
Agilent Technologies released the first commercial high-performance drift tube IM-MS instrument in 2014 (6560 IM-QToF), which offers an ion mobility resolving power of~70 (close to the theoretical diffusion limit 26 ) and allows for intrinsic measurement of CCS to a precision better than 0.5%. TIMS-MS was commercialized by Bruker, with the first instrument launched only in 2016, and consequently the impact of this technology is yet to be fully established.
Other types of IM-MS technology have yet to be utilized in the measurement of CCS for proteins and other biomolecules. For example, high-field asymmetric waveform ion mobility spectrometry (FAIMS) interfaces are commercially available and are among the highest resolving devices attainable. However, FAIMS separation relies on differences in mobilities at high and low electric field, and the theory of this separation is currently quite poorly understood with the exact characteristics controlling the mobility of an ion at high field apparently independent of m/z and the low-field CCS. Consequently, structural dimensions such as CCS cannot currently be directly and reliably extracted from the data. Other high-resolution IM technologies are emerging, including overtone IM 27 and cyclotron-type DTIMS analyzers. 28 While these are yet to be utilized for the description of biomacromolecular structure, they offer exciting possibilities for enhanced analysis in future. in protein electrospray mass spectra, along with automated mass analysis and measurement of relative peak intensities. 30, 31 Typically for protein assemblies, two-dimensional contact maps are first generated by observation of proteins and sub-complexes produced upon disruption of intact assemblies. Continued focus on gas-phase disruption methods, for example, high-energy collision-induced dissociation following extensive charge reduction or amplification, 32 surface-induced dissociation 33 commonly modelled using non-explicit methods, such as the 'projection approximation' (PA) 36, 37 and 'projection superposition approximation' (PSA), 38 or using hard-sphere collisions methods such as in 'exact hard sphere scattering' (EHSS). 39 Simple methods such as the PA essentially consider the 'shadow' 
| CRITICAL EVALUATION OF THE CCS MEASUREMENT
CCS is a macroscopic quantity that, although typically used to describe an intrinsic property of the analyte, is in fact specific to the drift gas as well as the temperature and electric field used during the measurement.
The fact that the CCS is not a true molecular cross section, but rather an observational property that averages all geometric orientations and ion-neutral interactions (such as glancing versus head on collisions, single versus multiple collisions within a cavity of the analyte, etc.) across the time frame of the IM separation, means that it is difficult to interpret the true meaning of this parameter.
Although IM-MS currently provides the most precise measurement of this parameter, by its nature, the structural information obtained is 'course-grained'; however, this level of granularity is of less concern when used to probe coarse features such as domain-level protein structures. in second-generation TWIMS instruments. 56 Proteins investigated using DMA technology have appeared to be more compact in the gas phase than previously thought, 21 of proteins and protein complexes, and, notably, it has been shown that different buffer gases yield different CCSs for identical conformations of a given ion. Furthermore, different gases can influence the conformations presented by gas-phase ions, particularly for natively folded forms. 57 A correct interpretation of IM data on any protein must therefore reconcile these effects, particularly when considering comparison across platforms or between experimental and theoretical values.
| HIGHLIGHTS OF QUANTITATIVE ION MOBILITY IN STRUCTURAL BIOLOGY
Characterization of proteins, and in particular the dynamic protein interactions that govern most critical cellular processes, is an ongoing goal in structural biology. High-resolution methods such as X-ray crystallography, NMR spectroscopy and, more recently cryo-electron microscopy (cryoEM) have dominated this field and have been highly successful in providing atomic level insight into a large number of protein complexes and interaction networks. However, intrinsic limitations of these techniques associated with factors such as protein flexibility and heterogeneity highlight the need to develop new approaches aimed at multi-protein structure determination, preferably on a high-throughput scale with broad scope. IM-MS offers promise to be a more sensitive, rapid and universal alternative to traditional structural biology methods, and can bridge the gap between generation of high-throughput data on protein interactions from proteomics and the structural biology field determining structures for isolated functional macromolecular complexes.
| Large protein assemblies
Early IM-MS studies of biomacromolecules were largely used to improve understanding of the relationship between solution-and gas-phase structures, by measurement of CCS values for isolated, small proteins. As it became clear that IM-MS can contribute important physiologically relevant details of conformation and dynamics, this method rapidly developed to also study larger and more heterogeneous assemblies. However, a major challenge for IM-MS in structural biology is the generation of accurate model structures for systems with limited or incomplete high-resolution data, and, ideally, from IM-MS constraints alone. First steps towards addressing this challenge have been demonstrated by Robinson and co-workers, through development of a computational approach that combines incomplete atomic structures with experimental constraints derived from CCS measurements to generate complete models of multiprotein complexes. 58 In this work, coarse-grained and homology modelling was used to 'fill-in' missing details from high-resolution experimental structures at both subunit and oligomer levels. Topological models were then constructed by determining the packing arrangements via known archetypal shapes and/or crystal symmetries that provide the best fit to the experimental CCS values ( Figure 3A) . The method therefore refines each building block using experimental data before larger oligomeric complexes are sequentially constructed.
The success of this approach was illustrated by application to multimeric protein complexes within the Escherichia coli replisome. replisome, and is likely to become more commonplace as the accuracy and precision of CCS measurements continue to improve.
| Membrane proteins
Structure determination of membrane protein assemblies in particular continues to define a substantial challenge in structural biology.
Membrane proteins constitute approximately 30% of a typical genome, and more than half of all membrane proteins are predicted to be pharmaceutical targets. 59 However, they contribute less than 1% of the structures currently deposited in the PDB. Relatively recent developments in native MS have seen renewed interest in the analysis of membrane proteins by this method, with the realization that membrane proteins can be transferred to the gas phase while encapsulated in lipid or detergent environments, before being and cyclic traveling wave 69 devices currently in development, it is expected that quantitative IM methods will be more routinely coupled with high-resolution MS measurement using, for example, Fourier transform ion cyclotron resonance (FTICR) and orbitrap mass analyzers.
IM devices for coupling with orbitrap mass analyzers already exist, including the recent release of FAIMS-Orbitrap instrumentation.
While the task of coupling DTIMS is not trivial due to the slow MS acquisition rates of these mass analyzers in comparison with IM separation times, recent reports suggest this may be soon
Model of early aggregation states of β 2 microglobulin. Monomeric β 2 microglobulin co-populates distinct native-like, partially folded, and unfolded states at acidic pH, while the dimer is a highly dynamic species. Initial association of the monomer to the dimer results in a dynamic trimer that undergoes structural change to a more stable species. The tetramer evolves in a similar manner, first forming with a dynamic structure that subsequently becomes stabilized. Further association proceeds by stacking elongated monomeric subunits. Reproduced with permission from Smith et al 65 achievable, 70 and would enable the ability to measure subtle variations in CCS for heterogeneous systems of similar mass and size, such as post-translationally modified proteins. A very recent report has even demonstrated the possibility of measuring protein CCSs without the need for an IM cell, by measuring the decay rate of a particular m/z signal in an orbitrap analyzer across the operating pressure range of the instrument. 71 While this approach does not currently match the analytical considerations of dedicated IM-MS methods, it may contribute to an ever greater integration of CCS measurements in structural biology.
An additional promising direction for IM-MS involves coupling with other gas-phase technologies to further enhance the structural information that can be afforded in a single experiment. IM-MS has recently been integrated with gas-phase infrared spectroscopy for protein analysis to provide additional insight at the secondary structure level. 72 Similarly, gas-phase conformations of amyloidogenic peptides have been studied by a combination of fluorescence resonance energy transfer (FRET) and IM, 73 and it can be expected that additional applications will arise. The general trend towards integrative structural biology, whereby data from multiple biophysical methods are combined to provide a more complete description of the system of interest, also provides further drive to integrate IM-MS with both other MS-based structural methods such as chemical cross-linking and hydrogen/deuterium exchange as well as other structural biology tools such as cryo-EM.
Outside the academic environment, the pharmaceutical industry represents a commercial sector with potential applications requiring quantitative IM-MS structural characterization of biomolecules.
Biopharmaceutically relevant molecules such as monoclonal antibodies and antibody-drug conjugates represent difficult structural targets due to their intrinsic flexibility, which contributes to a lack of full high-resolution coordinate files. Furthermore, a large amount of gas-phase collapse has been demonstrated for monoclonal antibodies, challenging structural interpretation. 74 Consequently, to date most biopharma applications involving proteins have utilized IM-MS in a manner aimed at resolution of structural isomers rather than direct CCS determination, leaving an underexplored application of CCS measurement, for example in evaluation of batch-to-batch variation.
Collision-induced unfolding experiments monitored by IM-MS also offer a complementary approach to distinguish subtle differences in large biotherapeutics (and other biomolecules), such as between IgG subclasses with different disulfide-bonding patterns. 75 Despite the current successes and future promise, a number of challenges remain in the quantitative analysis of CCS values from IM-MS experiments, primarily in the area of computational data interpretation. As described above, many sources of potential error still exist, from the measurement of absolute CCS values (particularly for TWIMS) and ensuring physiological relevance of the gas-phase measurement, to the generation of predicted CCS for theoretical structures to enable accurate comparison with experimental constraints.
In general, broad agreement has been observed between IM CCS values recorded for proteins and protein complexes with corresponding published X-ray structures. 42 However, while this holds true for the currently studied protein analytes, it is yet to be seen whether existing approaches are suitable to describe the multitude of diverse structures predicted across the proteome. Furthermore, a significant improvement is required in the computational prediction of protein structures or coarse-grained approximations in the absence of X-ray or NMR datasets in order to increase the scope and throughput of structure determination by IM-MS.
In summary, the measurement of protein CCS values by IM-MS must be carefully considered and evaluated. However, it can provide a valuable experimental constraint to define protein structures, often for systems which elude traditional structure biology approaches.
With continued technological advancement, and motivation to stretch this technology to ever more complex systems, it is expected that the applications of quantitative IM-MS in structural biology will greatly increase in coming years.
